2023 Q3 Form 10-Q Financial Statement

#000165495423010601 Filed on August 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $24.49K $28.56K $636.6K
YoY Change -98.61% -95.51% 213.62%
Cost Of Revenue $87.87K $55.82K $319.0K
YoY Change -92.53% -82.5% 358.89%
Gross Profit -$63.38K -$27.26K $317.7K
YoY Change -110.9% -108.58% 137.98%
Gross Profit Margin -258.83% -95.47% 49.9%
Selling, General & Admin $902.0K $618.1K $627.1K
YoY Change -86.27% -1.43% -27.08%
% of Gross Profit 197.41%
Research & Development $1.710M $1.671M $1.635M
YoY Change -6.79% 2.22%
% of Gross Profit 514.65%
Depreciation & Amortization $1.230M $1.219M $1.210M
YoY Change 0.06% 0.71% 135.03%
% of Gross Profit 380.93%
Operating Expenses $2.612M $2.289M $2.262M
YoY Change -68.92% 1.21% -363.01%
Operating Profit -$2.676M -$2.317M -$1.944M
YoY Change -65.79% 19.15% 167.61%
Interest Expense $44.27K -$33.13K $3.417K
YoY Change 8495.53% -1069.53% 0.0%
% of Operating Profit
Other Income/Expense, Net -$300.2K $7.180K $9.060K
YoY Change -3003.09% -20.75% -101.05%
Pretax Income -$2.976M -$2.350M -$1.954M
YoY Change -61.95% 20.25% 160.62%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.976M -$2.350M -$1.954M
YoY Change -61.95% 20.25% 160.62%
Net Earnings / Revenue -12151.77% -8228.78% -306.94%
Basic Earnings Per Share -$0.73 -$0.58
Diluted Earnings Per Share -$0.15 -$0.12 -$203.0K
COMMON SHARES
Basic Shares Outstanding 20.29M shares 20.04M shares 144.4M shares
Diluted Shares Outstanding 4.058M shares 4.019M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.370M $1.361M $1.754M
YoY Change -1.95% -22.4% 189.11%
Cash & Equivalents $2.371M $1.361M $1.754M
Short-Term Investments
Other Short-Term Assets $450.0K $241.2K $1.275M
YoY Change 195.26% -81.07% 935.43%
Inventory $217.3K $528.1K $670.5K
Prepaid Expenses
Receivables $162.00 $9.385K
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.040M $2.140M $3.699M
YoY Change -17.12% -42.15% 325.42%
LONG-TERM ASSETS
Property, Plant & Equipment $1.161M $1.269M $1.503M
YoY Change -14.03% -15.55% 6456.84%
Goodwill
YoY Change
Intangibles $29.42M
YoY Change
Long-Term Investments
YoY Change
Other Assets $235.2K $73.17K $124.7K
YoY Change 102.03% -41.32%
Total Long-Term Assets $30.82M $31.91M $36.71M
YoY Change -12.97% -13.09% 85.87%
TOTAL ASSETS
Total Short-Term Assets $3.040M $2.140M $3.699M
Total Long-Term Assets $30.82M $31.91M $36.71M
Total Assets $33.86M $34.05M $40.41M
YoY Change -13.36% -15.75% 95.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $670.0K $429.5K $2.598M
YoY Change -51.54% -83.47% 12532.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $684.0K $1.013M
YoY Change -100.0% -32.51% -40.79%
Long-Term Debt Due $40.00K $0.00 $3.377M
YoY Change -89.38% -100.0% 120.69%
Total Short-Term Liabilities $819.5K $1.114M $6.988M
YoY Change -69.0% -84.07% 194.1%
LONG-TERM LIABILITIES
Long-Term Debt $5.270M $2.500M $27.40M
YoY Change -90.88%
Other Long-Term Liabilities $89.33K $37.56K $18.32K
YoY Change 614.09% 105.03% -54.85%
Total Long-Term Liabilities $89.33K $37.56K $27.42M
YoY Change 614.09% -99.86% 67466.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $819.5K $1.114M $6.988M
Total Long-Term Liabilities $89.33K $37.56K $27.42M
Total Liabilities $6.179M $3.651M $34.41M
YoY Change 132.66% -89.39% 1323.64%
SHAREHOLDERS EQUITY
Retained Earnings -$31.96M -$28.99M -$14.16M
YoY Change 45.38% 104.66% 88.74%
Common Stock $202.9K $202.9K $1.444M
YoY Change 4.18% -85.94% 1.48%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $27.68M $30.40M $6.006M
YoY Change
Total Liabilities & Shareholders Equity $33.86M $34.05M $40.41M
YoY Change -13.36% -15.75% 95.97%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$2.976M -$2.350M -$1.954M
YoY Change -61.95% 20.25% 160.62%
Depreciation, Depletion And Amortization $1.230M $1.219M $1.210M
YoY Change 0.06% 0.71% 135.03%
Cash From Operating Activities -$740.0K -$1.151M -$229.3K
YoY Change -5.92% 402.06% 434.03%
INVESTING ACTIVITIES
Capital Expenditures $40.00K -$920.00 -$424.6K
YoY Change -116.31% -99.78% 1721.36%
Acquisitions
YoY Change
Other Investing Activities -$10.00K $135.9K
YoY Change -312.31% 339650.0%
Cash From Investing Activities -$50.00K $1.220K -$288.7K
YoY Change -79.21% -100.42% 1139.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.830M 1.391M 545.0K
YoY Change 11.18% 155.19% -16.23%
NET CHANGE
Cash From Operating Activities -740.0K -1.151M -229.3K
Cash From Investing Activities -50.00K 1.220K -288.7K
Cash From Financing Activities 1.830M 1.391M 545.0K
Net Change In Cash 1.040M 241.0K 27.08K
YoY Change 68.04% 789.84% -95.37%
FREE CASH FLOW
Cash From Operating Activities -$740.0K -$1.151M -$229.3K
Capital Expenditures $40.00K -$920.00 -$424.6K
Free Cash Flow -$780.0K -$1.150M $195.3K
YoY Change 44.08% -688.89% -1095.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1954032 usd
us-gaap Net Income Loss
NetIncomeLoss
-4870202 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
165687 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2403594 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2119719 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
8082596 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1269331 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
73169 usd
CY2023Q2 us-gaap Assets
Assets
34046402 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1954032 usd
us-gaap Net Income Loss
NetIncomeLoss
-4870202 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001014763
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000000 shares
CY2023Q2 aimd Accounts Receivable Related Party Current
AccountsReceivableRelatedPartyCurrent
177595 usd
CY2022Q4 aimd Accounts Receivable Related Party Current
AccountsReceivableRelatedPartyCurrent
177595 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20292624 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20292624 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20011602 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20011602 shares
CY2023Q2 aimd Convertible Notes Payable Noncurrent Related Party
ConvertibleNotesPayableNoncurrentRelatedParty
1500000 usd
CY2022Q4 aimd Convertible Notes Payable Noncurrent Related Party
ConvertibleNotesPayableNoncurrentRelatedParty
1500000 usd
aimd Estimated Net Realizable Values
EstimatedNetRealizableValues
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-20791
dei Entity Registrant Name
EntityRegistrantName
AINOS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TX
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-1974352
dei Entity Address Address Line1
EntityAddressAddressLine1
8880 Rio San Diego Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste. 800
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92108
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
869-2986
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20292624 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1360970 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9385 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
528114 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
241230 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
2139699 usd
CY2023Q2 aimd Intangible Assets Non Current
IntangibleAssetsNonCurrent
30564203 usd
CY2022Q4 aimd Intangible Assets Non Current
IntangibleAssetsNonCurrent
32806738 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
376526 usd
CY2023Q2 aimd Other Notes Payable Related Partycurrent
OtherNotesPayableRelatedPartycurrent
684000 usd
CY2022Q4 aimd Other Notes Payable Related Partycurrent
OtherNotesPayableRelatedPartycurrent
884000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
429503 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1212386 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1113503 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2472912 usd
CY2023Q2 aimd Convertible Notes Payable Noncurrent
ConvertibleNotesPayableNoncurrent
2500000 usd
CY2022Q4 aimd Convertible Notes Payable Noncurrent
ConvertibleNotesPayableNoncurrent
0 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
37562 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8096 usd
CY2023Q2 us-gaap Liabilities
Liabilities
3651065 usd
CY2022Q4 us-gaap Liabilities
Liabilities
2481008 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
202926 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
200116 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
59423678 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
58745149 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28985808 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24115606 usd
CY2023Q2 aimd Translation Adjustment Liability
TranslationAdjustmentLiability
-245459 usd
CY2022Q4 aimd Translation Adjustment Liability
TranslationAdjustmentLiability
-201653 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
30395337 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
34628006 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34046402 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37109014 usd
CY2023Q2 us-gaap Revenues
Revenues
28555 usd
CY2022Q2 us-gaap Revenues
Revenues
636627 usd
us-gaap Revenues
Revenues
77719 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
55817 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
318963 usd
us-gaap Cost Of Revenue
CostOfRevenue
156665 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
-27262 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
317664 usd
us-gaap Gross Profit
GrossProfit
-78946 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1671187 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1634856 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3370070 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
618149 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
627104 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1380614 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2289336 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
2261960 usd
us-gaap Operating Expenses
OperatingExpenses
4750684 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2316598 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1944296 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4829630 usd
CY2023Q2 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-40311 usd
CY2022Q2 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-18796 usd
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-49585 usd
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-35483 usd
CY2023Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
7182 usd
CY2022Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
9060 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
9013 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
8914 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-33129 usd
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9736 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-40572 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-26569 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2349727 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1954032 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4870202 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4053927 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2349727 usd
us-gaap Net Income Loss
NetIncomeLoss
-4053927 usd
CY2023Q2 aimd Net Earnings Per Share Basic And Diluted
NetEarningsPerShareBasicAndDiluted
-0.12
CY2022Q2 aimd Net Earnings Per Share Basic And Diluted
NetEarningsPerShareBasicAndDiluted
-0.20
aimd Net Earnings Per Share Basic And Diluted
NetEarningsPerShareBasicAndDiluted
-0.24
aimd Net Earnings Per Share Basic And Diluted
NetEarningsPerShareBasicAndDiluted
-0.42
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20095705 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9625133 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20053886 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9625133 shares
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2349727 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1954032 usd
us-gaap Net Income Loss
NetIncomeLoss
-4870202 usd
us-gaap Net Income Loss
NetIncomeLoss
-4053927 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
53867 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
43806 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
223746 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4914008 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4277673 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
32338424 usd
CY2023Q2 aimd Issuance Of Stock In Exchange Of Vehicle Amount
IssuanceOfStockInExchangeOfVehicleAmount
48559 usd
CY2023Q2 aimd Conversion Of Convertible Notes Payable To Common Stock Amount
ConversionOfConvertibleNotesPayableToCommonStockAmount
274789 usd
CY2023Q2 aimd Issuance Of Stock To Settle Vested Rsus Amount
IssuanceOfStockToSettleVestedRsusAmount
0 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
137159 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2349727 usd
CY2023Q2 aimd Translation Adjustment
TranslationAdjustment
-53867 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
30395337 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
43443 usd
CY2022Q2 aimd Translation Adjustment
TranslationAdjustment
-165687 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6006320 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
34628006 usd
aimd Issuance Of Stock In Exchange Of Vehicle Amount
IssuanceOfStockInExchangeOfVehicleAmount
48559 usd
aimd Conversion Of Convertible Notes Payable To Common Stock Amount
ConversionOfConvertibleNotesPayableToCommonStockAmount
274789 usd
aimd Issuance Of Stock To Settle Vested Rsus Amount
IssuanceOfStockToSettleVestedRsusAmount
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
357991 usd
us-gaap Net Income Loss
NetIncomeLoss
-4870202 usd
aimd Translation Adjustment
TranslationAdjustment
-43806 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
30395337 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10197107 usd
us-gaap Share Based Compensation
ShareBasedCompensation
86886 usd
us-gaap Net Income Loss
NetIncomeLoss
-4053927 usd
aimd Translation Adjustment
TranslationAdjustment
-223746 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6006320 usd
us-gaap Profit Loss
ProfitLoss
-4870202 usd
us-gaap Profit Loss
ProfitLoss
-4053927 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2423274 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2378835 usd
us-gaap Inventory Write Down
InventoryWriteDown
57474 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
357991 usd
us-gaap Share Based Compensation
ShareBasedCompensation
86886 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-192161 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
29881 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-10814 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-670507 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-55990 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-775909 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-684372 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
838484 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
9603 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
10125 usd
us-gaap Interest Expense Trading Liabilities
InterestExpenseTradingLiabilities
0 usd
us-gaap Interest Expense Trading Liabilities
InterestExpenseTradingLiabilities
606866 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2578453 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1629278 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
71262 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
424557 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-71262 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-424557 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1000000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
850000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1500000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
550000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
800000 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
114026 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
200000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2185974 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2200000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-28651 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-143787 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-492392 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2378 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1853362 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1751499 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1360970 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1753877 usd
us-gaap Interest Paid Net
InterestPaidNet
3122 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0 usd
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
26000000 usd
aimd Conversion Of Convertible Notes Payable To Common Stock And Accrued Interest Waived By Convertible Note Holders
ConversionOfConvertibleNotesPayableToCommonStockAndAccruedInterestWaivedByConvertibleNoteHolders
274789 usd
aimd Conversion Of Convertible Notes Payable To Common Stock And Accrued Interest Waived By Convertible Note Holders
ConversionOfConvertibleNotesPayableToCommonStockAndAccruedInterestWaivedByConvertibleNoteHolders
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
48559 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
us-gaap Increase Decrease In Payables To Customers
IncreaseDecreaseInPayablesToCustomers
0 usd
us-gaap Increase Decrease In Payables To Customers
IncreaseDecreaseInPayablesToCustomers
117185 usd
aimd Aggregate Public Offering
AggregatePublicOffering
780000 shares
CY2023Q2 us-gaap Share Price
SharePrice
4.25
CY2023Q2 aimd Exercise Price Of Share
ExercisePriceOfShare
4.25
us-gaap Conversion Of Stock Description
ConversionOfStockDescription
1-for-15
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of condensed financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosures as of the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on various factors, including historical experience, and on various other assumptions that are believed to be reasonable under the circumstances, when these carrying values are not readily available from other sources. Significant items subject to estimates and assumptions include useful lives of property and equipment, valuation of stock option and warrants, and impairment testing of intangible assets. Actual results may differ from these estimates.</p>
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1360970 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28985808 usd
aimd Inventory Textblock
InventoryTextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>4. Inventory </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inventory stated at cost, net of reserve, consisted of the following:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Raw materials</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">354,175</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">393,253</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Work in process</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">67,736</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">111,119</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Finished goods</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">106,203</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">90,850</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">528,114</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">595,222</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Inventory write-downs to estimated net realizable values were $14,694 and $ 57,474 for the three and six months ended June 30, 2023, respectively, compared to nil for the three and six months ended June 30, 2022.</p>
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
354175 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
393253 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
67736 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
111119 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
106203 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
90850 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
528114 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
595222 usd
CY2023Q2 aimd Estimated Net Realizable Values
EstimatedNetRealizableValues
14694 usd
aimd Estimated Net Realizable Values
EstimatedNetRealizableValues
57474 usd
CY2023Q2 aimd Convertible Notes Payable Related Party Current
ConvertibleNotesPayableRelatedPartyCurrent
0 usd
CY2022Q4 aimd Convertible Notes Payable Related Party Current
ConvertibleNotesPayableRelatedPartyCurrent
376526 usd
CY2023Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
684000 usd
CY2022Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
884000 usd
CY2023Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
3184000 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1260526 usd
CY2023Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3900 shares
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
137159 usd
us-gaap Share Based Compensation
ShareBasedCompensation
357991 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
43443 usd
us-gaap Share Based Compensation
ShareBasedCompensation
86886 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1439499 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M6D
CY2023Q2 aimd Earnings Loss Available To Common Shareholders Basic And Diluted
EarningsLossAvailableToCommonShareholdersBasicAndDiluted
-2349727 usd
CY2022Q2 aimd Earnings Loss Available To Common Shareholders Basic And Diluted
EarningsLossAvailableToCommonShareholdersBasicAndDiluted
-1954032 usd
aimd Earnings Loss Available To Common Shareholders Basic And Diluted
EarningsLossAvailableToCommonShareholdersBasicAndDiluted
-4870202 usd
aimd Earnings Loss Available To Common Shareholders Basic And Diluted
EarningsLossAvailableToCommonShareholdersBasicAndDiluted
-4053927 usd
CY2023Q2 aimd Weighted Average Number Of Shares Used In Computing Net Loss Per Share Attributable To Common Stockholders Basic And Diluted
WeightedAverageNumberOfSharesUsedInComputingNetLossPerShareAttributableToCommonStockholdersBasicAndDiluted
20095705 shares
CY2022Q2 aimd Weighted Average Number Of Shares Used In Computing Net Loss Per Share Attributable To Common Stockholders Basic And Diluted
WeightedAverageNumberOfSharesUsedInComputingNetLossPerShareAttributableToCommonStockholdersBasicAndDiluted
9625133 shares
aimd Weighted Average Number Of Shares Used In Computing Net Loss Per Share Attributable To Common Stockholders Basic And Diluted
WeightedAverageNumberOfSharesUsedInComputingNetLossPerShareAttributableToCommonStockholdersBasicAndDiluted
20053886 shares
aimd Weighted Average Number Of Shares Used In Computing Net Loss Per Share Attributable To Common Stockholders Basic And Diluted
WeightedAverageNumberOfSharesUsedInComputingNetLossPerShareAttributableToCommonStockholdersBasicAndDiluted
9625133 shares
CY2023Q2 aimd Net Loss Per Share Attributable To Common Stockholders Basic And Diluted
NetLossPerShareAttributableToCommonStockholdersBasicAndDiluted
-0.12
CY2022Q2 aimd Net Loss Per Share Attributable To Common Stockholders Basic And Diluted
NetLossPerShareAttributableToCommonStockholdersBasicAndDiluted
-0.20
aimd Net Loss Per Share Attributable To Common Stockholders Basic And Diluted
NetLossPerShareAttributableToCommonStockholdersBasicAndDiluted
-0.24
aimd Net Loss Per Share Attributable To Common Stockholders Basic And Diluted
NetLossPerShareAttributableToCommonStockholdersBasicAndDiluted
-0.42
CY2023Q2 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
633384 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
36666 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
633384 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
36666 shares
CY2023Q2 aimd Weighted Average Number Of Shares Warrants To Purchase Common Stock
WeightedAverageNumberOfSharesWarrantsToPurchaseCommonStock
966174 shares
CY2022Q2 aimd Weighted Average Number Of Shares Warrants To Purchase Common Stock
WeightedAverageNumberOfSharesWarrantsToPurchaseCommonStock
30174 shares
aimd Weighted Average Number Of Shares Warrants To Purchase Common Stock
WeightedAverageNumberOfSharesWarrantsToPurchaseCommonStock
966174 shares
aimd Weighted Average Number Of Shares Warrants To Purchase Common Stock
WeightedAverageNumberOfSharesWarrantsToPurchaseCommonStock
30174 shares
CY2023Q2 aimd Weighted Average Shares Outstanding Convertible Note Purchase Common Stock
WeightedAverageSharesOutstandingConvertibleNotePurchaseCommonStock
1666667 shares
CY2022Q2 aimd Weighted Average Shares Outstanding Convertible Note Purchase Common Stock
WeightedAverageSharesOutstandingConvertibleNotePurchaseCommonStock
9197405 shares
aimd Weighted Average Shares Outstanding Convertible Note Purchase Common Stock
WeightedAverageSharesOutstandingConvertibleNotePurchaseCommonStock
1666667 shares
aimd Weighted Average Shares Outstanding Convertible Note Purchase Common Stock
WeightedAverageSharesOutstandingConvertibleNotePurchaseCommonStock
9197405 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3266225 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9264245 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3266225 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9264245 shares
CY2023Q2 aimd Repurchase Agreements Interest Expense Amount1
RepurchaseAgreementsInterestExpenseAmount1
26000000 usd
CY2022Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
26000000 usd
CY2023Q2 aimd Interest Expense Incurred Related Party
InterestExpenseIncurredRelatedParty
23031 usd
aimd Interest Expense Incurred Related Party
InterestExpenseIncurredRelatedParty
26841 usd
CY2022Q2 aimd Interest Expense Incurred Related Party
InterestExpenseIncurredRelatedParty
18602 usd
aimd Interest Expense Incurred Related Party
InterestExpenseIncurredRelatedParty
34486 usd
CY2023Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
46712 usd
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
35282 usd
CY2023Q2 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
61157 shares
CY2023Q2 us-gaap Market Data Revenue
MarketDataRevenue
48559 usd

Files In Submission

Name View Source Status
0001654954-23-010601-index-headers.html Edgar Link pending
0001654954-23-010601-index.html Edgar Link pending
0001654954-23-010601.txt Edgar Link pending
0001654954-23-010601-xbrl.zip Edgar Link pending
aimd-20230630.xsd Edgar Link pending
aimd_10q.htm Edgar Link pending
aimd-20230630_def.xml Edgar Link unprocessable
aimd-20230630_cal.xml Edgar Link unprocessable
aimd-20230630_pre.xml Edgar Link unprocessable
aimd-20230630_lab.xml Edgar Link unprocessable
aimd_ex311.htm Edgar Link pending
aimd_ex312.htm Edgar Link pending
aimd_ex321.htm Edgar Link pending
aimd_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
aimd_10q_htm.xml Edgar Link completed